Licensed provider review·support@lumoramd.com·Log in
← Medications
MedicationWeight Management & Metabolic Health

Tirzepatide + B12.

Compounded tirzepatide combined with B12 to support energy during weight management.

5 / 10 / 15 / 20 / 25 / 30 mg tirzepatide with 0.5 mg B12 per mL · subcutaneous injectable

Pricing is shown after your free assessment, before you commit.

Start provider review →

Free to start. No card required.

Is this for you?

This is for you if

  • Patients on tirzepatide who experience fatigue during titration
  • Patients with low or borderline B12 levels
  • Patients who want fewer injections during their weight-management protocol

This isn't for you if

All safety information for tirzepatide applies — see the Tirzepatide product page. B12 is generally well tolerated; patients with cobalt or cobalamin sensitivity or Leber's hereditary optic neuropathy should consult their provider.

What it is

Tirzepatide + B12

This formulation pairs compounded tirzepatide — the dual GIP/GLP-1 receptor agonist — with vitamin B12 in a single weekly injection. B12 is added to support energy metabolism and address suboptimal levels that can worsen titration-phase fatigue.

How it works

Mechanism and fit.

Tirzepatide acts on both GIP and GLP-1 receptors, producing stronger appetite control, glucose regulation, and weight loss than GLP-1 alone for many patients. B12 supports energy production and red blood cell formation. Combined in one injection, the protocol reduces total injections.

When it may fit

Who this is typically for.

  • Patients on tirzepatide who experience fatigue during titration
  • Patients with low or borderline B12 levels
  • Patients who want fewer injections during their weight-management protocol
Tirzepatide + B12 - common questions

What patients
most often ask.

Is this the same as standalone tirzepatide?+

The tirzepatide component is identical. The B12 is added to address one of the common reasons patients struggle with energy during titration. It does not change the weight-loss effect of tirzepatide itself.

When it may fit

Who this is typically for.

These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.

  • <ul><li>Patients on tirzepatide who experience fatigue during titration</li><li>Patients with low or borderline B12 levels</li><li>Patients who want fewer injections during their weight-management protocol</li></ul>
Provider plan

How this option
is evaluated.

The plan is provider-determined after reviewing your assessment and safety factors.

  • DosingWeekly subcutaneous injection, titrated by your provider through the six concentration tiers.
  • Typical durationLong-term, individualized based on response and labs.
  • Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
How care works
  • A licensed provider reviews your assessment before any treatment is recommended.
  • You see full pricing - visit fees, medication, labs, follow-up - before you commit.
  • Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
  • Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.

Start with
provider review.

If you are considering Tirzepatide + B12, the first step is a free assessment. A provider determines whether it fits your goals and medical history.

Start provider review →

A provider determines whether treatment is clinically appropriate.

Important information
Lumora may prescribe FDA-approved or compounded medications when clinically appropriate. Compounded medications are not approved by the FDA and are dispensed by a licensed pharmacy under the supervision of a licensed provider.